Worldwide Vascular Graft Industry to 2025 – Increasing Prevalence of Lifestyle-related Disorders is Driving Growth –

Worldwide Vascular Graft Industry to 2025 – Increasing Prevalence of Lifestyle-related Disorders is Driving Growth –

Worldwide Vascular Graft Industry to 2025 – Increasing Prevalence of Lifestyle-related Disorders is Driving Growth –

DUBLIN–(BUSINESS WIRE)–The “Vascular Graft Market – Growth, Trends, and Forecasts (2020 – 2025)” report has been added to’s offering.

A vascular graft is a surgical procedure that redirects blood flow from one area of the body to another by reconnecting the blood vessels.

Key factors contributing to the market growth are rising prevalence of cardiac diseases, increasing prevalence of diabetes and end-stage renal diseases, coronary artery disease (CAD), hypertension, and cardiac aneurysms. Apart from the mentioned factors, genetic and hereditary factors, unhealthy lifestyle, alcohol consumption, and tobacco smoking, among others are expected to increase the demand for vascular grafts over the period. A low reimbursement rate and rising out-of-pocket expenses in an emerging economies can restrain market growth.

Companies Mentioned

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Bard Peripheral Vascular Inc. (BD)
  • Cardinal Health (Cordis Corporation)
  • Cook Medical
  • Cryolife
  • Getinge Group
  • LeMaitre Vascular Inc
  • Medtronic PLC
  • Terumo Medical Corporation
  • W.L. Gore & Associates Inc

Key Market Trends

Application in Kidney Failure is Expected to Register Robust Growth

The global prevalence of end-stage renal diseases (ESRD) is high and increasing at a significant rate. In 2017, 697.5 million cases of all-stage CKD were recorded, for a global prevalence of 9.1%, as per Global Burden of Disease Study 2017. It is found that chronic kidney diseases (CKD) may develop over many years leading to ESRD and lead to kidney failure. As per a 2018 report by the L. Y. Wong et al., published in International Journal of Nephrology, from 2007 to 2017 increased from approximately 12% to 17% and is further expected to increase to approximately 24% by 2035.

Kidney Failure is treated by replacing kidney through a kidney transplant. This process uses vascular grafts. The renal vessel is reconstructed in kidney transplantation using vascular grafts. Hence, increasing incidence of end-stage kidney failure is expected to increase the demand for vascular grafts as well, which will help the growth of the market.

North America is Expected to Retain Largest Market Share During the Forecast Period

North America dominates the vascular graft market. North America maintained its dominant share due to the high prevalence rate of diabetes, cardiovascular diseases, and chronic kidney disease. Presence of reimbursement coverage and availability of state-of-the-art healthcare infrastructure are driving the growth of this market in North America.

Asia-Pacific is anticipated to show the fastest growth during the forecast period due to increasing incidences of cardiovascular disease and diabetes and improving healthcare infrastructure.

Key Topics Covered:





4.1 Market Overview

4.2 Market Drivers

4.2.1 Increasing Prevalence of Lifestyle-related Disorders

4.2.2 Technological Advancements in the Scaffold Material and Design of Vascular Grafts

4.3 Market Restraints

4.3.1 Unfavorable Reimbursement Scenario

4.3.2 High Risk Associated with Graft Failures

4.4 Porter’s Five Force Analysis


5.1 By Product

5.1.1 Hemodialysis Access Graft

5.1.2 Endovascular Stent Graft

5.1.3 Peripheral Vascular Graft

5.1.4 Coronary Artery By-pass Graft

5.2 By Application

5.2.1 Aneurysms

5.2.2 Kidney Failure

5.2.3 Vascular Occlusion

5.2.4 Coronary Artery Diseases

5.2.5 Other Applications

5.3 By Raw Material

5.3.1 Synthetic Raw Material

5.3.2 Biological Raw Material

5.4 Geography

5.4.1 North America

5.4.2 Europe

5.4.3 Asia-Pacific

5.4.4 Middle-East and Africa

5.4.5 South America


6.1 Company Profiles

6.1.1 Abbott Laboratories

6.1.2 B. Braun Melsungen AG

6.1.3 Bard Peripheral Vascular Inc. (BD)

6.1.4 Cardinal Health (Cordis Corporation)

6.1.5 Cook Medical

6.1.6 Cryolife

6.1.7 Getinge Group

6.1.8 LeMaitre Vascular Inc

6.1.9 Medtronic PLC

6.1.10 Terumo Medical Corporation

6.1.11 W.L. Gore & Associates Inc


For more information about this report visit


Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900